Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab.
Saved in:
| Title: | Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab. |
|---|---|
| Authors: | Ullmann, Maeva1 (AUTHOR), Seipel, Katja1,2 (AUTHOR) martina.bertschinger@insel.ch, Nilius, Henning3 (AUTHOR), Bertschinger, Martina1,4 (AUTHOR), Rentsch, Vera1 (AUTHOR), Bacher, Ulrike2,4 (AUTHOR), Pabst, Thomas1,3 (AUTHOR) thomas.pabst@insel.ch |
| Source: | Cancers. Mar2026, Vol. 18 Issue 6, p930. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers18060930 |
